Publications by authors named "Jan de Monchy"

Claim this Profile
M
Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial.
Bjorn van Anrooij, Joanne N G Oude Elberink, Lambert F R Span, Jan G R de Monchy, Stefano Rosati

J Allergy Clin Immunol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.
Dorien J Buurman, Jan G R De Monchy, Reinout C A Schellekens, Laurens A van der Waaij, Jan H Kleibeuker

Scand J Gastroenterol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
Byrthe J P R Vos, Eveline van der Veer, Pieter C van Voorst Vader, André B Mulder, Sicco van der Heide, Jan G R de Monchy

J Allergy Clin Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.
Eveline van der Veer, Suzanne Arends, Sjoukje van der Hoek, Joris B Versluijs, Jan G R de Monchy

J Allergy Clin Immunol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
Bjorn van Anrooij, Eveline van der Veer, Jan G R de Monchy, Sicco van der Heide, Johanna C Kluin-Nelemans

J Allergy Clin Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of indolent systemic mastocytosis in a Dutch region.
Jasper J van Doormaal, Suzanne Arends, Kim L Brunekreeft, V Bauco van der Wal, Johanna Sietsma, Jan G R de Monchy

J Allergy Clin Immunol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab protects against allergen- induced bronchoconstriction in allergic (immunoglobulin E-mediated) asthma.
Stefan Zielen, Adrian Lieb, Stephan De La Motte, Frank Wagner, Jan de Monchy

Int Arch Allergy Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study.
Marie Louise A Schuttelaar, Pieter Jan Coenraads, Janneke Huizinga, Jan G De Monchy, Karin M Vermeulen

Contact Dermatitis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.
Stephen R Durham, Waltraud Emminger, Alexander Kapp, Jan G R de Monchy, Sabina Rak

J Allergy Clin Immunol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Desensitisation to circumvent hypersensitivity reactions; treatment with docetaxel still possible].
Jorien Luiting, Jan G R de Monchy, T J N Jeroen Hiltermann, J N G Hanneke Oude Elberink

Ned Tijdschr Geneeskd· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients.
Marek Niedoszytko, Marcel Bruinenberg, Jan de Monchy, Rinse K Weersma, Cisca Wijmenga

Ann Allergy Asthma Immunol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.
Maarten van den Berge, Ronald G Pauw, Jan G R de Monchy, Cees A van Minnen, Dirkje S Postma

Chest· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diagnostic model for the detection of sensitization to wheat allergens was developed and validated in bakery workers.
Eva Suarthana, Yvonne Vergouwe, Karel G Moons, Jan de Monchy, Diederick Grobbee

J Clin Epidemiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.
Marek Niedoszytko, Marcel Bruinenberg, Jan de Monchy, Cisca Wijmenga, Mathieu Platteel

J Allergy Clin Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.
Stephen R Durham, Waltraud Emminger, Alexander Kapp, Giselda Colombo, Jan G R de Monchy

J Allergy Clin Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mastocytosis in children: a protocol for management.
Rogier Heide, Auke Beishuizen, Hans De Groot, Jan C Den Hollander, Jasper J Van Doormaal, Jan G R De Monchy

Pediatr Dermatol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ciclesonide treatment on allergen-induced changes in T cell regulation in asthma.
Irene H Heijink, Henk F Kauffman, Edo Vellenga, Christa A Veltman-Starkenburg, Dirkje S Postma, Jan G R de Monchy

Int Arch Allergy Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.
Ronald Dahl, Alexander Kapp, Giselda Colombo, Jan G R de Monchy, Sabina Rak

J Allergy Clin Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
Marjolein L Donker, Jasper J van Doormaal, Frederiek F van Doormaal, Philip M Kluin, Eveline van der Veer, Jan G R de Monchy

Haematologica· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.
Sylvia H Kardaun, Jan G de Monchy

J Am Acad Dermatol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.
Ronald Dahl, Alexander Kapp, Giselda Colombo, Jan G R de Monchy, Sabina Rak

J Allergy Clin Immunol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.
Gail M Gauvreau, Louis Philippe Boulet, Dirkje S Postma, Tomotaka Kawayama, Richard M Watson, Jan G R De Monchy

J Allergy Clin Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes.
Irene H Heijink, Edo Vellenga, Jaap Oostendorp, Jan G R de Monchy, Dirkje S Postma

Am J Physiol Lung Cell Mol Physiol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of exposure to wheat flour and the shape of its relationship with specific sensitization.
Chava Peretz, Nettie de Pater, Jan de Monchy, Joke Oostenbrink, Dick Heederik

Scand J Work Environ Health· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
Irene H Heijink, Henk F Kauffman, Dirkje S Postma, Jan G R de Monchy, Edo Vellenga

Eur J Immunol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis